TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive In Brief: Kerman New President Of ACCC, David Johnson Names President Elect; Wyder Gets NY Award March 20, 1981
TCL Archive Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says November 28, 2014